Orkin, C., Squires, K. E., Molina, J., Sax, P. E., Wong, W., Sussmann, O., . . . Martin, E. A. (2019). Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial. Clin Infect Dis.
استشهاد بنمط شيكاغوOrkin, Chloe, et al. "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial." Clin Infect Dis 2019.
MLA استشهادOrkin, Chloe, et al. "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial." Clin Infect Dis 2019.